To
The Members,
Your Directors are pleased to present the 14th Annual Report on the business and
operations of the Company together with the Company's audited financial statements and the
auditors' report thereon for the financial year ended March 31, 2023. The financial
highlights for the year are given below:
1. Financial Results:
The financial performance, prospects, financial summary or highlights are as follows:
(Rs. In Lakhs)
| PARTICULARS |
STANDALONE |
CONSOLIDATED |
| Year Ended March 31, 2023 |
Year Ended March 31, 2022 |
Year Ended March 31, 2023 |
Year Ended March 31, 2022 |
| Revenue from operation and |
19,831.84 |
13474.36 |
19834.19 |
14311.63 |
| other income |
|
|
|
|
| Expenses (including |
18769.61 |
12704.84 |
18772.23 |
13441.56 |
| depreciation & amortization |
|
|
|
|
| expenses) |
|
|
|
|
| Profit before exceptional and |
1,062.22 |
769.52 |
1061.96 |
870.07 |
| extraordinary items and tax |
|
|
|
|
| Profit/(Loss) before tax |
1,062.22 |
769.52 |
1061.96 |
870.07 |
| Tax Expenses : |
|
|
|
|
| Current Tax |
182.75 |
128.45 |
182.83 |
145.22 |
| Deferred Tax |
62.45 |
-1.76 |
62.35 |
15.73 |
| MAT credit |
138.47 |
97.32 |
138.47 |
102.45 |
| Profit from the period from |
678.56 |
545.51 |
678.31 |
606.67 |
| continuing Operations |
|
|
|
|
| Minority share in Post |
- |
- |
- |
32.45 |
| Acquisition Profit /loss |
|
|
|
|
| Profit for the Period |
678.56 |
545.51 |
678.31 |
574.22 |
| Profit for the Period |
678.56 |
545.51 |
678.31 |
574.22 |
During the year under review, company has achieved the revenue of Rs.19831.84 Lakhs
(Rs. 13474.36 Lakhs in the previous year) The revenue of the company has been raised due
to increase in the sales price.
The overall expense of the Company has also increased by 47.73 % (increased from
12704.84Lakhs to 18769.61 Lakhs). Due to rise in the prices of cotton which is core raw
material. Profit after tax increased during the year under review.
2. State of Company's affairs and future outlook:
During the year under review, your company has expanded the business horizons in both
internal and external market, and also invested in one wholly owned subsidiary Mohini
Active Life Private Limited with the main object to manufacture diapers, sanitary napkins
and other related hygiene products. The Company has also diversified its investment from
its existing subsidiary Vedant Kotton Private Limited and Mohini Hygiene Care Products
Private Limited. The company has recently launch a new product Comber Noil. Now the
Company is mainly focus on efficient products with effective services and quality
standards are of utmost importance. We are continuously striving to grow by expanding the
market base, by introducing the best quality Surgical & Hygiene Products, and by
setting up high standards for the industry. This will not only uplift consumer
satisfaction level to a next level but will also give a quality product in the market at
competitive rates along in addition to prompt services.
3. Change in nature of business, if any
During the year under review, there has been no change in nature of business of the
Company.The Company has also inserted new objects in MOA by passing special resolution in
the last AGM held on 30th September, 2022.
4. Changes in Share Capital
There was no change in the Share Capital of the company during the year.
At present, the Company has only one class of shares- Equity shares of Rs. 10/- each.
The paid up share capital of the Company is Rs. 18,23,59,000/- divided into
1,82,35,900equity shares of Rs. 10/- each.
5. Credit Rating
Credit rating issued by India Ratings & Research (Ind-Ra) are as under:
| Facilities |
Amount(Rs. in millions) |
Rating |
| Fund-Based Working Capital Limits |
300 |
IND BBB-/Stable/IND A3 |
| Long-term/Term Loan |
67.60 |
IND BBB-/Stable |
| Fund-Based Working Capital Limits |
92.91 |
IND BBB-/Stable |
6. Amounts transferred to reserves
During the year under review, MAT Credit Entitlement of Rs. 138.47 lakhs and Profit of
Rs. 678.56 lakh has been transferred to the General Reserves.
7. Dividend
The Company intends to invest in future opportunities and therefore, your Directors
did not recommend any dividend for the year under review.
8. Material Changes between the end of financial year and the date of the Board
report There were no material changes and commitments affecting the financial position
of the Company occurred between the end of the financial year of the company to which
thefinancial statement relate and the date of the report.
9. Transfer of unclaimed dividend to investor education and protection fund The
provisions of Section 125(2) of the Companies Act, 2013 do not apply as no dividend was
declared and paid last year.
10. Subsidiary Company
A statement containing the salient features of the financial statements of subsidiary /
associates / joint venture companies, as per Section 129(3) of the Companies Act, 2013, in
Form AOC-1 is annexed as‘Annexure I'.
In accordance with third proviso of Section 136(1) of the Companies Act, 2013, the
Annual Report of the Company, containing therein its standalone and the consolidated
financial statements has been placed o n t h e w e b s i t e o f t h e C o m p a n y ,
www.mohinihealthandhygiene.com. Further, as per fourth proviso of the said section,
audited annual accounts of its Subsidiary Company have also been placed on the website of
the Company. Shareholders interested in obtaining a physical copy of the audited annual
accounts of the Subsidiary Companies may write to the Company Secretary requesting for the
same.
11. Annual Return
In accordance with the Companies Act, 2013, the annual return in the prescribed format
is available at https://mohinihealthandhygiene.com/investor_rela tions/annual-return/
12. Board Meetings
The Board meets at regular intervals to discuss and decide on business
strategies/policies and review the financial performance of the Company and its
subsidiaries. The notice of Board Meeting is given well in advance to all the Directors.
Usually, meetings of the Board are held in Pithampur. The Agenda for the Board Meetings
include detailed notes on the items to be discussed at the meeting to enable the Directors
to take an informed decision.
During the year under review, the Board of Directors met Five times on April 25, 2022,
May 30, 2022, ,August29, 2022, November 14, 2022, and March 10, 2023. The provisions of
Companies Act, 2013, Secretarial Standard 1 and the Listing Regulations were adhered to
while considering the time gap between two meetings.
13. Audit Committee
The Audit Committee comprises of Mr. Mukesh Vyas as a chairman, Mr. Mahesh Fogla, M r.
Mukul Jain and Mr. Sarvapriya Bansal as members. During the year under review, the
Committee met 5 (Five) times on
April 25, 2022, May 30, 2022, August29, 2022, November 14, 2022, and March 10, 2023.
The terms of reference of the Committee are in accordance with the provisions of
Section 177 of the Companies Act, 2013 and the Rules made thereunder.
14. Nomination and Remuneration Committee
The Nomination and Remuneration Committee comprises of Mr. Mukesh Vyas as a Chairman
and Mr. Mukul Jain and Mr. Chandrashekhar Bobra as members. During the year under review,
the Committee met 2 (Two) time on 29th August, 2022 and 10th March, 2023.
The terms of reference of the Committee are in accordance with the provisions of
Section 178 of the Companies Act, 2013 and Rules made thereunder.
15. Policy on Directors' Appointment and Remuneration and Other Details
In compliance with the requirements of Section 178 (3) of the Companies Act, 2013 and
Regulation 19 of the Listing Regulations, 2015, the Company has laid down a Nomination and
Remuneration Policy which has been uploaded on the Company's website. The web-link as
required under the Companies Act, 2013 is as under
https://mohinihealthandhygiene.com/wp-content/uploads/Nomination-and-Remuneration-Policy.pdf
The salient features of the NRC Policy areas under:
1. Setting out the objectives of the Policy 2. Definitions for the purposes of the
Policy
3. Policy for appointment and removal of Director, KMP and Senior Management 4. Policy
relating to the Remuneration for the Managerial Personnel, KMP, Senior Management
Personnel & other employees 5. Remuneration to Non-Executive / Independent Director
16. Stakeholders Relationship Committee
The Stakeholders Relationship Committee comprises of Mrs. Chandrashekhar Bobra as
Chairperson and Mr. Avnish Bansal and Mr. Saravapriya Bansal as members. During the year
under review, the Committee met 1(one) times on 14th November, 2022 The terms of reference
of the Committee are in accordance with the provisions of Section 178 of the Companies
Act, 2013 and Rules made there under.
17. Corporate Social Responsibility (CSR)
17.1 Corporate Social Responsibility (CSR) Committee
The Corporate Social Relationship Committee consists of Mrs. Parul Bansal as Chairman
and Mr. Sarvapriya Bansal and Mr. Chandrashekhar as members. During the year under review,
the Committee met 1 (One) time on 29th August, 2022. The terms of reference of the
Committee are in accordance with the provisions of Section 135 of the Companies Act, 2013
and Rules made there under.
17.2 Details of Policy developed and implemented by the Company on its Corporate Social
Responsibility initiatives
In compliance with requirements of Section 135 of the Companies Act, 2013, the Company
has laid down a CSR Policy to provide benefit to the weaker section of the Society. The
report on CSR activities carried out during the financial year ended 31st March, 2023 in
the form as prescribed under Rule 9 of the Companies (Corporate Social Responsibility
Policy) Rules, 2014 is annexed herewith as‘Annexure II'
18. Directors Responsibility Statement
In terms of provisions of Section 134 (5) of the Companies Act, 2013, the Board of
Directors hereby confirm that:- I.In the preparation of the Annual Accounts for the
financial year ended March 31, 2023, the applicable accounting standards had been followed
along with proper explanation relating to material departures; ii.The Directors have
selected such accounting policies as listed in financial statements and applied them
consistently and made judgments and estimates that are reasonable and prudent so as to
give a true and fair view of the state of the affairs of the Company at the end of the
financial year as on March 31, 2023 and of the profit of the Company for that period;
iii.The Directors have taken proper and sufficient care for the maintenance of adequate
accounting records in accordance with the provisions of the Act for safeguarding the
assets of the Company and for preventing and detecting fraud and other irregularities;
iv.The Directors have prepared the Annual Accounts on a going-concern basis; v.The
Directors have laid down internal financial controls to be followed by the Company and
that such internal financial controls are adequate and were operating effectively; and
vi.The Directors have devised proper systems to ensure compliance with the provisions of
all applicable laws and that such systems were adequate and operating effectively.
19. Declarationof Independence
Mr. Mukesh Vyas, Mr. Mukul Jain, Mr. Chandrashekhar Bobra and Mr. Mahesh Fogla are
Independent Directors of the Company. The Company has received declarations /
confirmations from all the Independent Directors of the Company as required under Section
149(7) of the Companies Act, 2013, read with Rule 6 of the Companies (Appointment and
Qualification of Directors) Rules, 2014..
Certificate under Regulation 34(3) of the Listing Regulations received from CS Nilam
Binjwa is attached in Annexure VII
20. Auditors
20.1 Statutory Auditor& their Report
The Members of the Company had, at their 12th AGM held on September 30, 2021, appointed
M/s Mahesh C. Solanki & Co. (FRN: 006228C)as the Statutory Auditor of the Company to
hold office for a term of five years commencing from the conclusion of the 12th AGM up to
the conclusion of 17th AGM of the Company to be held in the year 2026. The Notes to the
financial statements referred in the Auditors Report are self-explanatory and therefore do
not call for any comments under Section 134 of the Companies Act, 2013. The Auditors'
Report does not contain any qualification, reservation or adverse remark except The
company has booked insurance claim receivable amounting to Rs.25.04 Crores as on 31st
March, 2023. The claim lodged is under consideration and subject to confirmation by the
insurance company. We are unable to comment on appropriateness of assumption taken for
booking of insurance claim and any consequential impact, if any that may arise from this
matter . The Comments on the qualifications in the Auditors' Report on the financial
statements of the Company for financial year 2022-23 are provided in the “Statement
on Impact of Audit Qualifications” which is annexed as Annexure VIII and forms part
of this report.
20.2 Secretarial Auditor& their Report
Pursuant to the provisions of Section 204 of the Companies Act, 2013 and the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Board in its
meeting held on August 29, 2022 has appointed Ms. Neelam Binjwa, Practicing Company
Secretary, to conduct Secretarial Audit for the financial year 2022-23. The Secretarial
Audit Report for the financial year ended March 31, 2023 is annexed herewith marked as
‘Annexure III' to this Report. The Secretarial Audit Report does not contain any
qualification, reservation or adverse remark.
20.3 Internal Auditor
Pursuant to the provisions of Section 138 of the Companies Act, 2013 and the Companies
(Accounts) Rules, 2014, the Board in its meeting held on August 29, 2022 has appointed M/s
R. S. Bansal &Co , Chartered Accountant firm as an Internal Auditor of the Company to
conduct Internal Audit of records and documents of the Company for the financial year
2022-23.
21. Loans, guarantees or investments
The Particulars of loans, investments or guarantees have been disclosed in the
financial statements and the Company has duly complied with Section 186 of the Companies
Act, 2013 in relation to Loans, Investment and Guarantee during the financial year
2022-23.
22. Related Party Transactions
Related party transactions that were entered into during the financial year were on
arm's length basis and were in ordinary course of business. There are no materially
significant related party transactions made by the Company which may have potential
conflict with the interest of the Company.
There are no material related party transactions which are not in ordinary course of
business or which are not on arm's length basis and hence there is no information to be
provided as required under Section 134(3)(h) of the Companies Act, 2013 read with Rule
8(2) of the Companies (Accounts) Rules, 2014. The Board has approved a policy for related
party transactions which has been uploaded on the Company's website. The web-link as
required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is
as under:
https://mohinihealthandhygiene.com/wp-content/uploads/Policy-on-Related-Party-Transactions.pdf
Suitable disclosures as required under AS-18 have been made in the Note No 26 of the
financial statements.
23. Employee Stock Purchase Scheme
The Board of Directors and the Shareholders of the Company have approved the
‘Mohini Employee Stock Purchase Scheme 2020' (‘Scheme') in their Board Meeting
& Members meeting held on 24th August, 2020 and 29th September 2020 respectively. This
scheme is effective from 29th September 2020. Pursuant to the Scheme, the Company has,
constituted Mohini Employee Welfare Trust (‘Trust') to acquire, hold and
allocate/transfer equity shares of the Company to eligible employees from time to time on
the terms and conditions specified under the Scheme. The said trust has acquired Company's
equity shares aggregated to 4,53,000 equity shares from the secondary open market. The
disclosure in terms of Section 67 of the Act read with Rule 16of the Companies (Share
Capital and Debentures) Rules, 2014 is not applicable.
There is change in Trustees of Mohini Employee Welfare Trust. Mr. Vikas Jain is
appointed as a trustee with effect from 10th March, 2023 and Ms. Rajni Badole has resigned
from the post of Trustee with effect from 10th March, 2023.
The Disclosure as per SEBI (Share Based Employee Benefits and Sweat Equity)
Regulations, 2021 has been annexed herewith as Annexure VI and also on the website of the
Company under the following link: https://mohinihealthandhygiene.com/investor_rela
tions/annual-reports/
24. Conservation of energy, technology absorption, foreign exchange earnings and outgo
The information on conservation of energy, technology absorption and foreign exchange
earnings and outgo stipulated under Section 134(3)(m) of the Companies Act, 2013 read with
Rule 8 of Companies (Accounts) Rules, 2014, is annexed herewith as‘Annexure IV'.
25. Risk management policy of the Company
The Company has in place a mechanism to identify, assess, monitor and mitigate various
risks to key business objectives. Major risks identified by the businesses and functions
are systematically addressed through mitigating actions on a continuing basis. These are
discussed at the meetings of the Audit Committee and the Board of Directors of the
Company.
26. Formal Annual Evaluation:
Pursuant to the provisions of the Companies Act, 2013 and the SEBI (Listing Obligations
& Disclosure Requirements) Regulations, 2015, the Board has carried out an annual
performance evaluation of its own performance, the directors individually as well as the
evaluation of the working of its Audit, Nomination & Remuneration and Stakeholders
Relationship Committees.
27. Board of Directors and Key Managerial Personnel Directors Appointment &
Cessation
During the year, Mrs. Kiran Patidar ceased to be an Independent Director of your
Company w.e.f. August 30, 2022. The Board placed on record its sincere appreciation for
the services rendered by her during her tenure as an Independent Director of the Company.
Further the Board has appointed Mr. Viral Patel as an Executive Director with effect from
August 29, 2022 . The reappointment of Mr. Mukesh Vyas as an Independent Director of the
Company for consecutive further five years was approved in the last Annual General
Meeting,. Mr. Siddharth Jain ceased from 30th September, 2022 from Independent
directorship. Appointment of Mr. Mukul Jain as an Independent Director of the Company for
consecutive five years in the last Annual General Meeting held on 30th September, 2022.
Appointment of Mr. Mahesh Fogla as an Independent Director of the Company for consecutive
five years in the last Annual General Meeting held on 30th September, 2022. Appointment of
Mr. Chandrashekhar Bobra as an Independent Director of the Company for consecutive five
years in the last Annual General Meeting held on 30th September, 2022.
Key Managerial Personnel Appointment & Cessation Appointment of Mr. Anil Kumar
Singhania as a Chief Financial Officer of the Company w.e.f. 2nd September 2023.
Cessation of Mr. Yogesh Vijaywargiya , CFO from 2nd September 2023.
Appointment of Mr. Sarvapriya Bansal as a whole time Director of the Company in the
last Annual General Meeting held on 30th September, 2022. Appointment of Mrs. Parul Bansal
as a whole time Director of the Company in the last Annual General Meeting held on 30th
September, 2022. Appointment of Mr. Viral Patel as a Executive Director of the Company in
the last Annual General Meeting held on 30th September, 2022. Directors Liable to Retire
by Rotation and Being Eligible Offer themselves for Re-Appointment In accordance with
Articles of Association of the Company and the Companies Act, 2013, one-third of the total
Directors, other than Independent Directors of the Company, retire by rotation at every
Annual General Meeting and accordingly, Mr. Avnish Bansal (DIN:02666814) Director shall
retire by rotation at the forthcoming Annual General Meeting and being eligible, offers
himself for reappointment. Mr. Viral Patel DIN: 09662042 shall retire by rotation at the
forthcoming Annual General Meeting and being eligible, offers himself for reappointment.
The Company has received declaration from all the Independent Directors of the Company
confirming their registration with the databank of Independent Directors as notified by
Ministry
Of Corporate Affairs and also that they meet the criteria of independence as prescribed
under the Companies Act, 2013(‘Act') and SEBI (LODR) Regulations, 2015.
Review of performance of the Board
The Company has duly approved Nomination and Remuneration Policy prescribing inter-alia
the criteria for appointment, remuneration and performance evaluation of the directors. As
mandated by Section 134 & 178 read with Schedule IV of the Act and Regulation 25 of
the SEBI (LODR) Regulations, 2015 as applicable on the Company, the Independent Directors
in their separate meeting held on March 10, 2023 have reviewed the performance of
Non-Independent Directors, Chairperson and Board as a whole alongwith review of quality,
quantity and timeliness of flow of information between Board and management and expressed
their satisfaction over the same.
Furthermore, Board is of the opinion that Independent directors of the company are
persons of high repute, integrity & possess the relevant expertise & experience in
their respective fields. The Certificate of Non-Disqualification of Directors (Pursuant to
Regulation 34(3) and clause (10)(i) of Para C of Schedule V of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015) is hereby received from
Secretarial Auditor CS Neelam Binjwa is attached as AnnexureVII
Composition of Board of Directors
Details of Board of Directorsand Key Managerial Personnel (KMP) of the Company is as
follows:
| Name |
Designation |
Date of Appointment & Cessation |
| Mr. Sarvapriya Bansal |
Whole-time Director |
Appointment w.e.f. 24th June, 2009. Change in |
|
|
designation on 30th September, 2022 |
| Mr. Avnish Sarvapriya Bansal |
Managing Director |
Appointment w.e.f. 24th June, 2009. |
| Mrs. Parul Bansal |
Whole time Director |
Appointment w.e.f. 31st January, 2017. Change in |
|
|
designation on 30th September, 2022 |
| Mr. Viral Patel |
Executive Director |
Appointment w.e.f. 29th August, 2022 |
| Mr. Mukesh Vyas |
Non-Executive Independent Director |
Reappointment w.e.f. 29th August, 2022 |
| Mr. Mukul Jain |
Non-Executive Independent Director |
Appointment w.e.f. 29th August, 2022 |
| Mr. Mahesh Fogla |
Non-Executive Independent Director |
Appointment w.e.f. 29th August, 2022 |
| Mr. Chandrashekhar Bobra |
Non-Executive Independent Director |
Appointment w.e.f. 29th August, 2022 |
| Mr. Yogesh Vijaywargiya |
Chief Financial Officer |
Ceassed w.e.f 2nd September, 2023 |
| Mrs. Arnika Jain |
Company Secretary |
28th March, 2019 |
| Mr. Siddharth Jain |
Non-Executive Independent Director |
Ceassed w.e.f 30th September, 2022 |
| Mrs. Kiran Patidar |
Non-Executive Independent Director |
Ceassed w.e.f 30th August, 2022 |
| Mr. Anil Kumar Singhania |
Chief Financial Officer |
Appointment w.e.f. 2nd September, 2023 |
Internal Financial Control
Your Company has well defined and adequate internal controls and procedures,
commensurate with its size and nature of its operations. The Company's internal control
procedures which includes internal financial controls; ensure effective compliance with
various policies, practices and statutes keeping in view the organization's pace of growth
and increasing complexity of operations. The internal auditors' team carries out extensive
audits throughout the year and submits its reports to the Audit Committee of the Board of
Directors.
28. Disclosure on establishment of a Vigil Mechanism Pursuant to the provisions of
Section 177(9) & (10) of the Companies Act, 2013 and the SEBI (Listing Obligationsand
Disclosure Requirements) Regulations, 2015, a Vigil Mechanism or Whistle Blower Policy for
directors, employees and other stakeholders to report genuine concerns has been
established. The same is uploaded on the website of t h e C o m p a ny a n d t h e w e b -
l i n k i s https://mohinihealthandhygiene.com/wp-content/uploads/Vigil-Mechanism.pdf
29. Particulars of employees and related disclosures
There was no employee drawing remuneration in excess of limits prescribed under section
197 (12) of the Companies Act, 2013 read with Rule 5 (2) and 5 (3) of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014. Disclosures pertaining
to remuneration and other details as required under section 197 (12) of the Companies Act,
2013 read with Rule 5 (1) of the Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014 has been appended as‘Annexure V' of this Report.
30. Corporate Governance
The equity shares of the Company are listed on Emerge Platform of National Stock
Exchange of India Limited (NSE).As per Regulation 15 (2) of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015, Para C of Schedule
V relating to Corporate Governance Report, shall not apply to Companies listed on SME
Exchange. Hence, report on Corporate Governance does not form part of this Annual Report.
31. Management Discussion and Analysis Report
The Report on Management Discussion and Analysis for the Financial Year ended March 31,
2023 is annexed as‘Annexure IX' to this Report.
32. Listing of Securities
The equity shares of the Company are listed on Emerge Platform of NSE with security
symbol ‘MHHL'. The Company has paid the annual listing fees to NSE and annual custody
fees to NSDL and CDSL.
33. Other statutory disclosures and information
33.1 There have been no material changes/ commitments affecting the financial
position of the Company which have occurred between the end of the financial year to which
the financial statements relate and the date on report; 33.2. During the year under
review,the Company has not accepted the deposit from the public under section 73 to 76 of
the Companies Act, 2013 and the rules made there under; 33.3. During the year,
there is no fraud which has been reported to the Audit Committee / Board. 33.4.
Pursuant to Regulation 34(2)(f) of SEBI (Listing Obligations & Disclosure
Requirements) Regulations, 2015, business responsibility report is not applicable to your
Company for the financial year ending March 31, 2023.
33.5. The Company has approved the Mohini Employee Stock Purchase Scheme 2020
and also made provision of money for the purchase of its own shares by employees or by
trustees for the benefit of employees; 33.6. No fraud has been reported by the
Auditors to the Audit Committee or the Board; 33.7. No significant or material
orders were passed by the Regulators or courts or tribunals which impact the going concern
status and Company's operations in future; 33.8. There have been no instances of
any revision in
the Board Report or the financial statement, hence disclosure under Section 131(1) of
the Companies Act, 2013 is not required; 33.9. The Company has not paid any
commission to any of its Directors and hence, provision of disclosure of commission paid
to any Director as mentioned in Section 197(14) of the Companies Act, 2013 is not
applicable; and 33.10. The Company has not issued (a) any shares with differential
voting rights (b) Sweat Equity shares (c) shares under any Employee stock option scheme,
hence no disclosures are required to be made as per the Companies (Share Capital and
Debentures) Rules, 2014; 33.11. The Central Government has not prescribed the
maintenance of cost records by the Company under Section 148(1) of the Companies Act, 2013
for any of its products; and 33.12. The Company has complied with the provisions
relating to the constitution of Internal Complaints Committee under the Sexual Harassment
of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 to redress
complaints received regarding sexual harassment.
34. Details of application made or any proceeding pending underthe Insolvency
and Bankruptcy Code, 2016 (31 of 2016) andtheir status
There are no application made or any proceeding pending under the Insolvency and
Bankruptcy Code, 2016 (31 of2016) during the year
35. Details of difference between amount of the Valuation done at the time of
One Time Settlement and the Valuation done whiletaking loans from the Banks or Financial
Institution alongwiththe reasons thereof .
There are no such events occurred during the period from April 01, 2022 to March 31,
2023, thus no valuation iscarried out for the one-time settlement with the Banks
orFinancial Institutions.
36. Acknowledgment
The Directors thank all the shareholders, customers, dealers, suppliers, bankers,
financial institutions and all other business associates for their continued support to
the Company and the confidence reposed in its Management. The Directors also thank the
Government authorities for their understanding and co-operation. The Directors wish to
record their sincere appreciation of the significant contribution made by the employees of
the Company at all levels to its profitable and successful operations.
| FOR AND ON BEHALF OF THE BOARD OF DIRECTORS OF |
|
| MOHINI HEALTH & HYGIENE LIMITED |
|
| MR. AVNISH SARVAPRIYA BANSAL |
MRS. PARUL BANSAL |
| MANAGING DIRECTOR |
WHOLETIME DIRECTOR |
| DIN: 02666814 |
DIN: 06856466 |
| DATE: 2nd SEPTEMBER, 2023 |
|
| PLACE: PITHAMPUR (M.P.) |
|
|